The potential therapeutic effect of statins in multiple sclerosis: beneficial or detrimental effects

In conclusion, the effects of statins on MS neuropathology seem to be conflicting, as statins seem to be protective in the acute phase of MS through anti-inflammatory and antioxidant effects. However, statins lead to detrimental effects in the chronic phase of MS by reducing brain cholesterol and inhibiting the remyelination process.
Source: Inflammopharmacology - Category: Drugs & Pharmacology Source Type: research